2.17
+0.065(+3.10%)
Currency In USD
| Previous Close | 2.1 |
| Open | 2.15 |
| Day High | 2.19 |
| Day Low | 2.11 |
| 52-Week High | 3.25 |
| 52-Week Low | 0.82 |
| Volume | 309,240 |
| Average Volume | 492,640 |
| Market Cap | 57.83M |
| PE | -3.09 |
| EPS | -0.7 |
| Moving Average 50 Days | 2.29 |
| Moving Average 200 Days | 1.91 |
| Change | 0.07 |
If you invested $1000 in Spectral AI, Inc. (MDAI) since IPO date, it would be worth $223.2 as of September 18, 2025 at a share price of $2.165. Whereas If you bought $1000 worth of Spectral AI, Inc. (MDAI) shares 3 years ago, it would be worth $219.35 as of September 18, 2025 at a share price of $2.165.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
DeepView® System highlighted at the European Burns Association Congress
GlobeNewswire Inc.
Sep 10, 2025 12:00 PM GMT
DALLAS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, tod
Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call
GlobeNewswire Inc.
Jul 30, 2025 12:00 PM GMT
DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System and focused on medical diagnostics for faster and more accurate treatment decisions in wound care, to
Spectral AI Announces Submission to FDA of its DeepView® System
GlobeNewswire Inc.
Jun 30, 2025 12:00 PM GMT
DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in